[HTML][HTML] Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

C Gao, J Jiang, Y Tan, S Chen - Signal transduction and targeted …, 2023 - nature.com
Microglia activation is observed in various neurodegenerative diseases. Recent advances in
single-cell technologies have revealed that these reactive microglia were with high spatial …

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases

JP Quinn, SE Kandigian, BA Trombetta… - Brain …, 2021 - academic.oup.com
Neurosecretory protein VGF (non-acronymic) belongs to the granin family of neuropeptides.
VGF and VGF-derived peptides have been repeatedly identified in well-powered and well …

[HTML][HTML] Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias

YL Chai, JH Lee, JR Chong, C Ballard… - Journal of …, 2023 - Springer
Background Chronically dysregulated neuroinflammation has been implicated in
neurodegenerative dementias, with separate studies reporting increased brain levels of …

[HTML][HTML] The crosstalk between microbiome and mitochondrial homeostasis in neurodegeneration

F Borbolis, E Mytilinaiou, K Palikaras - Cells, 2023 - mdpi.com
Mitochondria are highly dynamic organelles that serve as the primary cellular energy-
generating system. Apart from ATP production, they are essential for many biological …

[HTML][HTML] Neuroinflammation in dementia with Lewy bodies: a human post-mortem study

J Amin, C Holmes, RB Dorey, E Tommasino… - Translational …, 2020 - nature.com
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative cause of
dementia, behind Alzheimer's disease (AD). It is now established that cerebral inflammation …

Systematic review of pharmacological interventions for people with Lewy body dementia

KE Watts, NJ Storr, PG Barr, AP Rajkumar - Aging & mental health, 2023 - Taylor & Francis
Objective Lewy body dementia (LBD) is the second most common neurodegenerative
dementia, and it causes earlier mortality and more morbidity than Alzheimer's disease …

[HTML][HTML] Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers

LL Gibson, C Abdelnour, J Chong… - Current Opinion in …, 2023 - journals.lww.com
Clinical trials in dementia with Lewy bodies: the evolving c... : Current Opinion in Neurology
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient …

[HTML][HTML] Co-expression network analysis identifies molecular determinants of loneliness associated with neuropsychiatric and neurodegenerative diseases

JA Santiago, JP Quinn, JA Potashkin - International Journal of Molecular …, 2023 - mdpi.com
Loneliness and social isolation are detrimental to mental health and may lead to cognitive
impairment and neurodegeneration. Although several molecular signatures of loneliness …

[HTML][HTML] Elucidating distinct molecular signatures of Lewy body dementias

J Harvey, E Pishva, L Chouliaras, K Lunnon - Neurobiology of Disease, 2023 - Elsevier
Dementia with Lewy bodies and Parkinson's disease dementia are common
neurodegenerative diseases that share similar neuropathological profiles and spectra of …

[HTML][HTML] Investigation of inflammation in Lewy body dementia: a systematic scoping review

PM Loveland, JJ Yu, L Churilov, N Yassi… - International Journal of …, 2023 - mdpi.com
Inflammatory mechanisms are increasingly recognized as important contributors to the
pathogenesis of neurodegenerative diseases, including Lewy body dementia (LBD). Our …